GRACE THERAPEUTICS INC (GRCE) Forecast, Price Target & Analyst Ratings

NASDAQ:GRCE • US00439U1043

Current stock price

4.55 USD
-0.04 (-0.87%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GRACE THERAPEUTICS INC (GRCE).

Forecast Snapshot

Consensus Price Target

Price Target
$11.73
+ 157.80% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jun 26, 2026
Period
Q4 / 2026
EPS Estimate
-$0.25
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.73
Upside
+ 157.80%
From current price of $4.55 to mean target of $11.73, Based on 8 analyst forecasts
Low
$11.11
Median
$11.73
High
$12.60

Price Target Revisions

1 Month
0.00%
3 Months
-1.43%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for GRCE. The average price target is 11.73 USD. This implies a price increase of 157.8% is expected in the next year compared to the current price of 4.55.
The average price target has been revised downward by 1.43% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

GRCE Current Analyst RatingGRCE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

GRCE Historical Analyst RatingsGRCE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
GRCE was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GRCE.
In the previous month the buy percentage consensus was at a similar level.
GRCE was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-02-18HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jun 26, 2026
Period
Q4 / 2026
EPS Estimate
-$0.25
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-349.90%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
30.00%

Next Earnings Summary

GRCE is expected to report earnings on 6/26/2026. The consensus EPS estimate for the next earnings is -0.25 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
GRCE revenue by date.GRCE revenue by date.
200K
-100.00%		8.721M37.383M
328.65%		102.07M
173.04%		142.9M
40.00%		183.73M
28.57%		214.35M
16.67%		239.87M
11.91%
EBITDA
YoY % growth
GRCE ebitda by date.GRCE ebitda by date.
-31.34M
-136.17%		-22.12M
29.42%		-9.8M
55.70%		N/A
-56.53%		N/A
-18.19%		-14.37M
37.36%		-17.034M
-50.00%		-10.098M
40.72%		-11.832M
-17.17%		3.672M
131.03%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
GRCE ebit by date.GRCE ebit by date.
-33.67M
-119.35%		-24.44M
27.41%		-10.72M
56.14%		-13.543M
-43.10%		-15.228M
-18.97%		-12.342M
37.72%		-17.823M
-56.80%		-11.322M
36.48%		-13.872M
-22.52%		1.632M
111.76%		64.305M
3,840.26%		99.214M
54.29%		134.12M
35.18%		159.03M
18.57%		178.93M
12.51%
Operating Margin
GRCE operating margin by date.GRCE operating margin by date.
N/AN/A-5,360.00%N/AN/AN/AN/AN/A-159.06%4.37%63.00%69.43%73.00%74.19%74.59%
EPS
YoY % growth
GRCE eps by date.GRCE eps by date.
-41.82
-0.99%		N/A
47.07%		N/A-0.67-1.98
-194.20%		-1.47
57.12%		-1.22
10.47%		-0.86
-13.35%		-0.66
23.67%		0.29
144.19%		1.63
461.82%		2.45
49.98%		2.55
4.17%		2.96
16.01%		3.27
10.35%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.25
-349.90%		-0.17
17.43%		-0.19
-223.00%		-0.16
-16.57%		-0.12
51.02%		-0.08
52.94%		0.00
100.00%		0.04
125.00%		0.11
191.67%
Revenue
Q2Q % growth		408K1.02M2.346M3.57M4.59M
1,025.00%		6.324M
520.00%		8.058M
243.48%		9.894M
177.14%
EBITDA
Q2Q % growth		-2.958M
6.86%		-3.264M
-5.70%		-3.57M
-41.27%		-2.958M
-21.03%		-2.04M
31.03%		-1.224M
62.50%		408K
111.43%		1.428M
148.28%		2.958M
245.00%
EBIT
Q2Q % growth		-3.06M
3.86%		-3.774M
-22.14%		-4.08M
-61.33%		-3.468M
-41.61%		-2.55M
16.67%		-1.734M
54.05%		-102K
97.50%		918K
126.47%		2.448M
196.00%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

GRCE Yearly Revenue VS EstimatesGRCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
GRCE Yearly EPS VS EstimatesGRCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -10 -20 -30 -40

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
7.01%
EPS Next 5 Year
31.44%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
1.36%
EBIT Next 5 Year
23.12%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

GRACE THERAPEUTICS INC / GRCE Forecast FAQ

Can you provide the average price target for GRACE THERAPEUTICS INC stock?

8 analysts have analysed GRCE and the average price target is 11.73 USD. This implies a price increase of 157.8% is expected in the next year compared to the current price of 4.55.

What is the next earnings date for GRCE stock?

GRACE THERAPEUTICS INC (GRCE) will report earnings on 2026-06-26.

Can you provide the consensus estimates for GRACE THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of GRACE THERAPEUTICS INC (GRCE) is -0.25 USD and the consensus revenue estimate is 0 USD.